Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Learn when to harvest losses in index funds to optimize your tax outcome. This intro explains timing factors, safe harbors, and how to avoid wash-sale pitfalls.
14,321 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
A key Fed signal is rippling through crypto markets. This guide explains what happened, which cryptocurrencies may be...
Two traders file a civil suit accusing Polymarket of misresolving a Strategy bitcoin sale market after a late May dis...
Large ADA holders have accelerated selloffs in early July, pushing Cardano into a fresh trough. Traders are watching ...
When a top executive sells a large block, investors want to know what it really signals. This analysis breaks down th...
A divorced listener earning about $100,000 was advised to liquidate home equity to wipe out debt, a move that reignit...
A $1 million BTC bet tied to a UFC comeback did not pay out, reigniting the meme of the Drake Curse. Here’s what happ...
New data show a sharp drop in ACA marketplace enrollment after subsidies ended, with millions faced with higher costs...
SpaceX stock stumbled since its IPO has sparked questions about what comes next. By charting historical IPO patterns ...
A Utah-based defamation suit accuses Kevin O’Leary and Fox News of tying two local political groups to the CCP amid o...
SpaceX stock appears to be trading well below its IPO price, but price alone doesn’t determine value. Here’s a practi...
A respected investment firm hints that the crypto market might be near a bottom. Here’s what that could mean for Coin...